Annie Dalby, once classified as “obese” according to the Body Mass Index (BMI), has shared her remarkable weight loss journey after shedding 1.5 stone. She credits her success to a weight-loss jab called Wegovy, which contains the active ingredient semaglutide. Prior to trying Wegovy, Annie had experimented with various diets like WeightWatchers, Slimming World, and the intense Cambridge Diet, but found herself battling with weight regain each time.
Despite maintaining a healthy diet and regular exercise routine, Annie struggled with weight management, particularly due to challenges brought on by an underactive thyroid triggered during her second pregnancy. However, since starting Wegovy in mid-May, Annie has managed to lose 21 pounds. Wegovy, also known as semaglutide, is not only aiding in weight loss for Annie but has also had a profound impact on her overall well-being.
Annie expressed her awe at the effectiveness of semaglutide, likening it to a “brain transplant” due to its ability to silence the constant “food noise” she previously experienced. The medication has eliminated the distractions and stress associated with food cravings, allowing Annie to focus on a healthier lifestyle without the burden of constant hunger. Additionally, Elin Skoglund, an MD, explained the concept of “food noise” and how semaglutide targets the brain’s reward system to reduce these intrusive thoughts about food.
Semaglutide, also found in the medication Ozempic, is approved for weight loss in the UK and is available on the NHS for weight management, alongside liraglutide-based medication Saxenda. Both medications work by helping patients feel fuller and must be prescribed by a specialist weight management service. They are intended to be used in conjunction with diet and exercise regimens. Semaglutide is prescribed based on certain BMI criteria for individuals with weight-related health issues. Liraglutide, on the other hand, is suitable for those with specific health conditions and risk factors for heart complications.
Although Wegovy has been approved to reduce the risk of heart attacks and strokes for individuals with heart and circulatory diseases, Dr Deborah Lee of Dr Fox Online Pharmacy has highlighted potential side effects such as nausea, diarrhoea, and constipation. It is essential to consult with healthcare professionals before starting these medications to ensure they are suitable for individual health needs.
In conclusion, Annie Dalby’s success story with Wegovy exemplifies the positive impact that weight-loss jabs like semaglutide can have on individuals struggling with weight management. The medication’s ability to address underlying issues related to food cravings and support healthier lifestyle choices makes it a promising option for those seeking effective weight loss solutions.